ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P 500
5,505.00
-0.71%
US Tech 100
19,134.80
0.66%
Dow Jones
40,287.53
-0.93%
Brent Oil
81.745
-0.65%
Bitcoin
67,403.68
-1.11%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Xeris Biopharma Holdings Inc (XERS)

  7. Xeris Biopharma Holdings Inc (XERS) News

XERS

Xeris Biopharma (XERS)

Xeris Biopharma Holdings Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:XERS
DateTimeSourceHeadlineSymbolCompany
07/08/20247:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
07/08/20247:00AMBusiness WireXeris Biopharma Announces CEO Succession PlanNASDAQ:XERSXeris Biopharma Holdings Inc
07/03/20241:05PMBusiness WireXeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
06/05/20244:19PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
06/05/20244:15PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
06/03/20247:00AMBusiness WireXeris Presents New Post Hoc Analysis on Effects of Levoketoconazole (Recorlev®) in Cushing’s Syndrome Patients at ENDO 2024NASDAQ:XERSXeris Biopharma Holdings Inc
05/30/20247:30AMBusiness WireXeris Biopharma Announces Positive Topline Phase 2 Clinical Data of Its Investigational XeriSol™-Formulated Once-Weekly Subcutaneous (SC) Levothyroxine (XP-8121)NASDAQ:XERSXeris Biopharma Holdings Inc
05/30/20247:00AMBusiness WireXeris to Participate in the Jefferies Global Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
05/09/20247:14AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
05/09/20247:00AMBusiness WireXeris Biopharma Reports First Quarter 2024 Financial Results and Recent EventsNASDAQ:XERSXeris Biopharma Holdings Inc
05/06/20247:00AMBusiness WireXeris Enters Into an Exclusive Worldwide Collaboration and License Agreement with Beta BionicsNASDAQ:XERSXeris Biopharma Holdings Inc
05/02/20247:00AMBusiness WireXeris Biopharma to Report First Quarter 2024 Financial Results on May 9, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
04/03/20244:05PMBusiness WireXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
04/02/20247:00AMBusiness WireXeris Biopharma to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
03/06/20244:19PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:XERSXeris Biopharma Holdings Inc
03/06/20244:10PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:XERSXeris Biopharma Holdings Inc
03/06/20247:27AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
03/06/20247:02AMBusiness WireXeris Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results and Recent EventsNASDAQ:XERSXeris Biopharma Holdings Inc
03/06/20247:00AMBusiness WireXeris Refinances Its $150M Senior Secured Term Loan Facility With Hayfin CapitalNASDAQ:XERSXeris Biopharma Holdings Inc
02/28/20247:00AMBusiness WireXeris Biopharma to Report Fourth Quarter and Full Year 2023 Financial Results on March 6, 2024NASDAQ:XERSXeris Biopharma Holdings Inc
02/05/20247:00AMBusiness WireXeris to Present at the Oppenheimer 34th Annual Healthcare Life Science ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
01/31/20245:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
01/10/202410:12AMDow Jones NewsXeris Biopharma Shares Climb 12% on Amgen License AgreementNASDAQ:XERSXeris Biopharma Holdings Inc
01/10/20248:53AMDow Jones NewsXeris Biopharma Reaches License Agreement With Amgen On Thyroid Eye Disease TreatmentNASDAQ:XERSXeris Biopharma Holdings Inc
01/10/20248:00AMBusiness WireXeris Biopharma Enters Into an Exclusive Worldwide License Agreement for Xeriject® Formulation of TeprotumumabNASDAQ:XERSXeris Biopharma Holdings Inc
01/05/20244:05PMBusiness WireXeris Pharmaceuticals Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:XERSXeris Biopharma Holdings Inc
01/04/20247:09AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:XERSXeris Biopharma Holdings Inc
01/04/20247:00AMBusiness WireXeris Biopharma Updates Its Outlook for 2023NASDAQ:XERSXeris Biopharma Holdings Inc
12/27/20237:00AMBusiness WireXeris Biopharma to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:XERSXeris Biopharma Holdings Inc
11/21/20234:16PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:XERSXeris Biopharma Holdings Inc
 Showing the most relevant articles for your search:NASDAQ:XERS

Your Recent History

USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
HIRU
Hiru (PK)
USOTC
BIEL
Bioelectronics (PK)
USOTC
SPZI
Spooz (PK)
USOTC
RONN
Ronn Motor (PK)
USOTC
VPLM
Voip Pal Com (QB)
COIN
BTCUSD
Bitcoin
NASDAQ
COOP
Mr Cooper
NASDAQ
AVXL
Anavex Life Sciences
NASDAQ
LWLG
Lightwave Logic
USOTC
DBMM
Digital Brand Media and ... (PK)
USOTC
NWBO
Northwest Biotherapeutics (QB)
USOTC
NSAV
Net Savings Link (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
AXXA
Exxe (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved